XU Fang, WANG Lei, MEI Peipei, GENG Longyu, ZHANG Miujia, ZHOU Lanlan. Influence of continuous nursing on prognosis of ankylosing spondylitis[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 124-127, 132. DOI: 10.7619/jcmp.20213394
Citation: XU Fang, WANG Lei, MEI Peipei, GENG Longyu, ZHANG Miujia, ZHOU Lanlan. Influence of continuous nursing on prognosis of ankylosing spondylitis[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 124-127, 132. DOI: 10.7619/jcmp.20213394

Influence of continuous nursing on prognosis of ankylosing spondylitis

More Information
  • Received Date: August 23, 2021
  • Available Online: December 02, 2021
  • Published Date: November 14, 2021
  •   Objective  To explore the effect of continuous nursing on prognosis of patients with ankylosing spondylitis (AS).
      Methods  A total of 200 AS patients were enrolled in this study and randomly divided into experimental group and control group. Ninety-seven cases were eventually in the experimental group and 92 cases were included in the control group. The control group was given routine nursing, and the experimental group was given routine nursing combined with continuous nursing intervention. The disease activity, mental state and quality of life of patients in the baseline period and one year after treatment were statisticallyanalyzed in the two groups.
      Results  There was no significant difference in baseline clinical data between the two groups (P>0.05). After one year of treatment, the improvement degree of quality of life and mental state of patients in the experimental group was significantly higher, and the adherence rate of biological agents was significantly higher than that in the control group (P < 0.05).
      Conclusion  Although continuous nursing can not increase the remission rate of disease activity in patients with AS, but it can significantly improve their psychological state, quality of life and prognosis.
  • [1]
    谢雅, 杨克虎, 吕青, 等. 强直性脊柱炎/脊柱关节炎患者实践指南[J]. 中华内科杂志, 2020, 59(7): 511-518. doi: 10.3760/cma.j.cn112138-20200505-00448
    [2]
    SIEPER J, PODDUBNYY D. Axial spondyloarthritis[J]. Lancet, 2017, 390(10089): 73-84. doi: 10.1016/S0140-6736(16)31591-4
    [3]
    RITCHLIN C, ADAMOPOULOS I E. Axial spondyloarthritis: new advances in diagnosis and management[J]. BMJ, 2021, 372: m4447. http://www.bmj.com/content/372/bmj.m4447/related
    [4]
    AGARWAL G, CROOKS V A. The nature of informational continuity of care in general practice[J]. Br J Gen Pract, 2008, 58(556): e17-e24. doi: 10.3399/bjgp08X342624
    [5]
    DAVIS K M, ECKERT M C, HUTCHINSON A, et al. Effectiveness of nurse-led services for people with chronic disease in achieving an outcome of continuity of care at the primary-secondary healthcare interface: a quantitative systematic review[J]. Int J Nurs Stud, 2021, 121: 103986. doi: 10.1016/j.ijnurstu.2021.103986
    [6]
    孙学明, 刘冰, 姬栋岩. 国内外延续性护理研究进展[J]. 世界最新医学信息文摘, 2017, 17(34): 36-37. https://www.cnki.com.cn/Article/CJFDTOTAL-WMIA201734019.htm
    [7]
    田家利, 公冶慧娟, 刘宇, 等. 慢性病患者延续性护理的研究现状[J]. 中国护理管理, 2017, 17(1): 108-111. doi: 10.3969/j.issn.1672-1756.2017.01.027
    [8]
    赵越, 张莉芸, 茹晋丽. 强直性脊柱炎疗效评估指标的研究进展[J]. 中华风湿病学杂志, 2010, 14(2): 135-138. doi: 10.3760/cma.j.issn.1007-7480.2010.02.019
    [9]
    李鲁, 王红妹, 沈毅. SF-36健康调查量表中文版的研制及其性能测试[J]. 中华预防医学杂志, 2002, 36(2): 109-113. doi: 10.3760/j:issn:0253-9624.2002.02.011
    [10]
    JANE ZOCHLING. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S)[J]. Arthritis Care & Research (Hoboken), 2011, 63(Suppl 11): S47-58. http://www.onacademic.com/detail/journal_1000033734864110_9a16.html
    [11]
    王征宇, 迟玉芬. 焦虑自评量表(SAS)[J]. 上海精神医学, 1984(2): 73-74. https://www.cnki.com.cn/Article/CJFDTOTAL-JSYI198402008.htm
    [12]
    孙振晓, 刘化学, 焦林瑛, 等. 医院焦虑抑郁量表的信度及效度研究[J]. 中华临床医师杂志: 电子版, 2017, 11(2): 198-201. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYD201702005.htm
    [13]
    BARALIAKOS X, KOENIG A S, JONES H, et al. Predictors of clinical remission under anti-tumor necrosis factor treatment in patients with ankylosing spondylitis: pooled analysis from large randomized clinical trials[J]. J Rheumatol, 2015, 42(8): 1418-1426. doi: 10.3899/jrheum.141278
    [14]
    段振华, 潘发明, 梅杨, 等. 强直性脊柱炎患者445例流行特征分析[J]. 中国公共卫生, 2011, 27(3): 341-342. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGW201103043.htm
    [15]
    顾春芳, 仇雅云, 汤悦煦. 强直性脊柱炎患者生活质量影响因素分析[J]. 中国医学前沿杂志: 电子版, 2017, 9(10): 145-148. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201710036.htm
    [16]
    陈冬微. 延续性护理对强直性脊柱炎患者生活质量及依从性的影响[J]. 心理月刊, 2019, 14(12): 82. https://www.cnki.com.cn/Article/CJFDTOTAL-XLYK201912066.htm
    [17]
    徐培, 曹保媛, 晁佳, 等. 网络延续护理对强直性脊柱炎出院患者治疗依从性及功能状态的影响[J]. 护理实践与研究, 2016, 13(15): 11-13. https://www.cnki.com.cn/Article/CJFDTOTAL-HLSJ201615004.htm
    [18]
    程菱, 何颖, 徐玫, 等. 延续护理对内热针治疗后强直性脊柱炎患者疼痛与生活质量的影响[J]. 湖北中医药大学学报, 2018, 20(6): 99-101. https://www.cnki.com.cn/Article/CJFDTOTAL-HZXX201806028.htm
    [19]
    乔延青. 网络平台在强直性脊柱炎病人出院后延续护理中的应用效果分析[J]. 全科护理, 2017, 15(33): 4167-4168. https://www.cnki.com.cn/Article/CJFDTOTAL-JTHS201733031.htm
    [20]
    陈侠, 陈思思, 林仲可, 等. 专科护士指导强直性脊柱炎患者自我管理的临床实践及效果评价[J]. 中华现代护理杂志, 2019(18): 2261-2266.
  • Cited by

    Periodical cited type(19)

    1. 李翠如,徐萌,赵怡婷. 血清CEA、NSE、CYFRA21-1联合检测在不同病理类型肺癌诊断中的应用. 中国实用医刊. 2024(09): 81-84 .
    2. 朱锋. 血清人附睾蛋白4与细胞角蛋白19片段及鳞状上皮细胞癌抗原联合检测对肺癌的预测价值. 医疗装备. 2024(14): 69-71 .
    3. 黄永杰,赵铁锁,李晓童,李灵招. 血清CYFRA21-1、VEGF、AFP、CA19-9和SCC水平对食管癌的诊断价值. 河南医学研究. 2024(19): 3490-3494 .
    4. 刘秋影. 肺癌患者血清NSE、SCC、CYFRA21-1水平变化及临床意义研究. 现代诊断与治疗. 2024(15): 2342-2343+2367 .
    5. 袁亦红. 血清NSE、CEA、及CYFRA21-1联合检测对肺癌的诊断价值分析. 现代诊断与治疗. 2024(17): 2656-2658 .
    6. 王卓童,周月霞,赵玉娟. 血清淀粉样蛋白A与肿瘤标志物联合检测在肺癌诊断中的应用研究. 系统医学. 2023(02): 50-53 .
    7. 陈礼昌,滕凤猛. 血清肿瘤标志物在肺癌不同病理分型中的应用价值. 临床误诊误治. 2022(01): 29-32+47 .
    8. 张吉炯,张健. 微小RNA-508-3p靶向调控配对盒基因2影响肺癌细胞生物学特性的分子机制研究. 实用临床医药杂志. 2022(02): 62-68+75 . 本站查看
    9. 谢文瑞,于艳华. 三种肿瘤标志物在肺腺癌诊断中的意义. 中国肿瘤临床与康复. 2022(03): 316-319 .
    10. 陈敬,王敏,万霞,黄凤敏. 非小细胞肺癌患者鳞状上皮细胞癌抗原、人附睾蛋白水平检测在预后评估中的应用价值分析. 实用医院临床杂志. 2022(03): 128-130 .
    11. 康丝雨. 血清CEA等4种肿瘤标志物联合检测在诊断肺癌中的价值. 医疗装备. 2022(10): 41-42 .
    12. 胡见英. 血清HE4、CEA水平联合检测对肺癌诊断和预后的意义. 中国卫生标准管理. 2022(11): 71-73 .
    13. 崔洪恩,姚宣. 分析电化学发光免疫分析仪检测血清肿瘤标志物在肺癌诊断中的应用价值. 系统医学. 2022(15): 73-76 .
    14. 冯玉梅. NSE、CYfra21-1联合检测对肺癌患者的诊断价值. 系统医学. 2022(24): 88-90+94 .
    15. 林道烺,陈洁琼,于鹏飞,林平,陈瑀. 神经元特异性烯醇化酶、细胞角蛋白19片段抗原21-1联合癌胚抗原在老年肺癌诊断中的应用. 中国临床实用医学. 2021(04): 25-28 .
    16. 庄学山,李毅俊. 探究肿瘤标志物检验用于肺癌诊断的应用价值. 中外医疗. 2021(24): 185-188 .
    17. 陈冬,姚成,高文仓,庞德湘. 血清神经元特异性烯醇化酶、循环肿瘤细胞和乳酸脱氢酶水平在小细胞肺癌诊断及治疗中的价值. 中国基层医药. 2021(12): 1809-1813 .
    18. 晏亮,刘艳. 肿瘤标志物应用于肺癌检验的临床价值. 中国当代医药. 2021(33): 164-166 .
    19. 王晨亮,彭丽姿,周兵. 血清肿瘤标志物在肺癌诊断和病理组织分型中的价值. 中国当代医药. 2021(33): 167-169+179 .

    Other cited types(1)

Catalog

    Article views (259) PDF downloads (27) Cited by(20)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return